Mr James Acheson

Mr James AchesonTel: 020 3448 3382 / 020 3447 9740
Fax: 0203 448 4339
Email: james.acheson@uclh.nhs.uk

Location:
National Hospital for Neurology and Neurosurgery

Specialities:
Neuro-ophthalmology, Neurology and neurosurgery

Professional background

Joint Consultant Neuro-Ophthalmologist at National Hospital for Neurology and Neurosurgery and Moorfields Eye Hospital, appointed 1999
Consultant Ophthalmologist, National Hospital and St.Mary's Hospital (Western Eye Hospital) 1992 -1999
Fellowship training in Neuro-Ophthalmology, St.Thomas' Hospital 1991
Registrar training in Ophthalmology, Moorfields Eye Hospital and Western Eye Hospital, 1986- 91
Basic General medicine and Neurology training 1982- 1985
BM University of Southampton 1980

Research interests

Clincial Neuro-Ophthalmology

Publications

Clayton LM, Duncan JS, Sisodiya SM, Acheson JF. Delayed, rapid visual field loss in a patient after ten years of vigabatrin therapy. Eye. 2010; 24(1), 185-6.
Ali N, Woodward CE, Sweeney M, Phadke R, Holton JL, Acheson J, Plant GT, Bremner FD. Pupillary dysfunction in an atypical case of mitochondrial myopathy with tubular aggregates.  J Neuroophthalmol. 2010 Jun;30(2):153-6.
Rahi JS, Cumberland PM, Peckham CS; British Childhood Visual Impairment
Interest Group. Improving detection of blindness in childhood: the British
Childhood Vision Impairment study. Pediatrics. 2010 Oct;126(4):e895-903.
Clayton LM, Devile M, Punte T, Kallis C, de Haan G-J, Sander JW, Acheson JF, Sisodiya SM. The relationship between visual field size and retinal nerve fibre layer thickness in patients exposed to the anti-epileptic drug vigabatrin. Ann Neurol. 2011 69(5). 845-54
Ali N, Acheson J. Hemifacial presentation of mitochondrial myopathy
J Neurol. 2011 285(5), 923-4

GMC/GDC number: 2634232